Reprinted with permission from JustSecurity
President Donald Trump's announcement on May 18 that he had secretly begun taking the anti-malaria drug hydroxychloroquine 10 days before coincides with the revelation that two senior White House aides tested positive for COVID-19 and the sudden initiation of a White House policy for staffers to wear masks. When press secretary Kayleigh McEnany explained the new White House Policy back then, she did not disclose, perhaps because she did not know, that the president was taking hydroxychloroquine. "I think it's good," Trump said on Monday. "I've heard a lot of good stories. And if it's not good, I'll tell you right. I'm not going to get hurt by it."